From Around The Web

Aphria yanks forecast due to coronavirus after strong increase in cannabis sales

Jefferies analyst says Aphria’s COVID-19 measures should not detract from ‘stellar operational quarter’

Aphria bought C$30 million worth of weed because of production delays at one of its facilities.

Aphria Inc. told investors Wednesday that cannabis sales jumped 65% in its most recent quarter, but pull-backs from wholesale buyers across Canada due to COVID-19 forced the company to rescind guidance for the full year.